Skip to content

Clinical trials

Phase 1/2 Neoplasm Metastasis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1/2 Country / region: Australia Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20131
20142
20161
20171
20191
20205
20218
202210
20233
20242
20252
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting21
Terminated10
Active, not recruiting7
Completed5
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ascendis Pharma Oncology Division A/S2
AstraZeneca2
Novartis Pharmaceuticals2
Nuvalent Inc.2
Pfizer2
Takeda2
AllVascular1
Array BioPharma1
Aulos Bioscience, Inc.1
BioAtla, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis44
Carcinoma, Non-Small-Cell Lung14
Neoplasms12
Colorectal Neoplasms10
Endometrial Neoplasms8
Breast Neoplasms7
Lung Neoplasms7
Melanoma7
Ovarian Neoplasms5
Squamous Cell Carcinoma of Head and Neck5

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.